Call Us: Monday - Friday 9 AM - 7:30 PM EST
Effective Medical Equipment & Financing

Physicians Options

Introduction: What is D’OXYVA?

D’OXYVA®   is the only painless, non-invasive, transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

D’OXYVA has recorded instant, outsized, and sustained improvements of the autonomic nervous system (ANS) in the brain, enhanced parasympathetic (rest & digest) nerve activities, tissue perfusion and blood circulation in macro-, and microcirculation, chronic wound closure and balanced blood pressure, in controlled human clinical trials (Phase I to III).

Based on years of experience, D’OXYVA has continued developing this microcirculation therapy. This process, unique to D’OXYVA, has demonstrated triggering protective physiological functions in the body: vasodilation and vasoconstrictions in the vessels, catalyzing vessel structure growth (angiogenesis), autoregulation of local blood supply in tissues and organs, neuroreceptor signaling in the brain and balancing blood pH, among other critical functions.

Interested in Learning More About ANS Testing and Treatment Equipment?

Talk with our medical equipment specialists by calling 954-451-6395 or filling out the contact form below.

Pair ANS Testing with D’OXYVA® for improved clinical efficacy and billing.

Using the Intellewave, a state of the art comprehensive autonomic nervous system testing system, we can establish initial vitals for each and every patient before prescribing D’OXYVA. The Intellewave measures precise heart rate variability and beat to beat blood pressure monitoring and information about the patients sympathetic and parasympathetic systems in the body.

The Intellewave Difference:

There are many systems that claim the ability to automatically measure the Autonomic Nervous System. Measuring the dysfunction of the sympathetic and parasympathetic systems renders a plethora of data to physicians.

However, the Intellewave measures the system in real time over an extended period using ECG electrocardiogram based testing, rather than PPG or plethysmography based testing. Not only has CMS Medicare deemed ECG testing more accurate but also more comprehensive than its PPG counterpart.

The Intellewave system provides maximum flexibility and diversity with its holistic mobile cart management system that allows physicians to provide world class holistic testing of the autonomic nervous system in less than 30 mins. The seamless and intuitive red, yellow, green reports that follow will allow doctors to easily assess where patients lay in comparison to normal standard deviation of a healthy patient Autonomic nervous system.

This information allows us to establish a baseline from which we can monitor and gauge improvement. After you have taken the initial baseline test, apply D’OXYVA, a 5 minute treatment application, wait 30 minutes, and retest the patient with the Intellewave ANS system. Recheck all vitals mentioned above, and the numbers should speak for themselves, and should correspond with the reduction in symptoms the patient feels.

These tangible results substantiated with ANS testing show both the doctor and the patient what D’OXYVA can do even in just 1 treatment application.

Neuropathy patients that are treated by doctors working within this program are thrilled with their results.

TAKING D’OXYVA DAILY, USERS HAVE REPORTED A NUMBER OF QUALITY OF LIFE BENEFITS BEYOND SIGNIFICANTLY REDUCING RISKS OF CHRONIC CONDITIONS, INCLUDING BUT NOT LIMITED TO:

  • Relief from symptoms of microvascular complications
  • Significantly increased cardiac function, physical fitness, endurance and strength, muscle size, body tone, faster recovery from sports injuries and surgical trauma
  • Promoting and maintaining a healthy weight, improving general mobility, deeper, more restful sleep
  • Significant improvement of mental acuity; concentration, heightened stamina, energy, and focus while managing stress
  • Improved vitals across the board during checkups with zero adverse event reports after years of regular use by people with various health, demographic, and ethnic backgrounds

*Six years of excellent user feedback and over two dozen clinical studies demonstrated outsized results at clinics and at home with zero adverse events. For example, D’OXYVA® (deoxyhemoglobin vasodilator) has been recording significant results also as a varicose vein treatment while delivering major clinical outcomes for well over 90% of users. Average results rounded for display, based on number of enrolled subjects in each clinical study with D’OXYVA and user feedback.
Read D’OXYVA Clinical Evidence >>

Specifications, Pricing & Financing